Bayer said after publishing its earnings outlook for 2020 it was in no rush to reach terms with plaintiffs' lawyers and was less inclined to set aside funds for any deal following recent U.S. decisions in its favour. | Bayer photo

Bayer cools prospect of imminent glyphosate settlement

LEVERKUSEN, Germany, (Reuters) – German drugs and pesticides company Bayer was at pains to quell expectations last week that it was nearing an out-of-court settlement laying to rest claims its glyphosate-based weedkillers cause cancer. Bayer said after publishing its earnings outlook for 2020 it was in no rush to reach terms with plaintiffs’ lawyers and […] Read more

Incoming BASF boss rules out DowDuPont-style break-up

FRANKFURT (Reuters) – The incoming boss of BASF has thrown his weight behind the chemical titan’s contentious strategy of keeping divergent businesses folded into one company, at a time when its major rivals such as DowDuPont are breaking themselves up. The comments from Martin Brudermueller, who will take over as CEO on Friday, provide clarity […] Read more